Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Medical Activist and Novelist J.T Madicus Introduces "Final Diagnosis: No Second Chances"

Novelist J.T. Madicus, otherwise known as Future Doc House, announces release of his first of five written works in "Final Diagnosis" series. Combining his real-life experience in medical science with his love of fiction, this medical drama/thriller teaches its audience medicine. It's now available on Amazon for purchase.


News provided by

J.T. Madicus

Jun 09, 2020, 08:10 ET

Share this article

Share toX

Share this article

Share toX

Medical Activist, "Final Diagnosis: No Second Chances" Author & Filmmaker, J.T. Madicus
Medical Activist, "Final Diagnosis: No Second Chances" Author & Filmmaker, J.T. Madicus

LOS ANGELES, June 9, 2020 /PRNewswire-PRWeb/ -- Most thrillers begin with a staccato burst of gunfire, not the rapping of knuckles on a wooden door. J.T. Madicus, otherwise known as Future Doc House, is turning the genre on its head with his debut novel "Final Diagnosis: No Second Chances." Setting the stage as the first of five works in the series, it combines the novelist's experience in medical science with his love of fiction to create a medical drama/thriller that teaches its audience medicine. Proudly introducing Dr. Tseng to the world, its captivating plot embeds real-life medical scenarios allowing the reader to watch its heroes analyze, diagnose, and treat patients. Though both the characters and the plot are fiction, the medical cases are factual.

Tseng's whirlwind introduction includes being kidnapped, transported to an unknown location in central Europe, and dropped into an operating theater with a cadaverous body on the table and a crew of medical experts he knows only by reputation. If they can cure their patient of a mysterious illness, they will earn their freedom. The novel combines a gripping narrative with tense action scenes and medical puzzles, which could double as recommended reading for medical students.

“This all began as a teaching exercise for medical students, but the characters took on lives of their own. Dr. Tseng, Dr. Liz, Jeff, and the others are real people to me now, and their exploits keep me awake at night."

Post this

"This all began as a teaching exercise for medical students, but the characters took on lives of their own," Madicus said. "Dr. Tseng, Dr. Liz, Jeff, and the others are real people to me now, and their exploits keep me awake at night. Other people feel the same, even the first proof-readers for the novel said they couldn't put it down!"

Madicus began writing the book, in part, as a way to distract himself from the ever-evolving rigors of the medical field. Approximately 30 percent of medical students will experience depression at some point in their training. Medical school is highly competitive and relatively joyless. Student debt can be overwhelming. Doctors are nearly twice as likely to commit suicide when compared to the general population.

"I studied medicine in three different countries," Madicus said. "I know first-hand that, no matter where you look, the joy and excitement is missing from medical education. This novel is my contribution towards putting that spark back in. We're talking about addiction, redemption, and healing not just medically, but also emotionally. Both the medical plotlines and the character arcs dwell on the question: Can a broken person be made whole again? This is something I have always been driven to explore."

While the puzzling medical mysteries will appeal to medical students and professionals, the psychological tension, strongly developed characters, and fast-paced plot will be entertaining to both the average reader as well as the medical expert. Two additional novels in the five-book series are well underway and "Final Diagnosis: No Second Chances" has already taken life into the form of a film set to premiere in Summer 2020.

Madicus no doubt has his stethoscope on the pulse of the future of medicine with several other projects, including QUPI.com, the largest medical question bank on the market. Created for medical students, QUPI exists to solve the problem of the shortage of doctors by making it fun and easy to practice medical knowledge through cutting-edge educational content and software technology online and by way of an app. His analysis of the state of healthcare and medical education in the United States, "Is There a Doctor Aboard? An Urgent Call for Change in Medical Education and Government Policy" does not paint a pretty picture. QUPI's mission is to revolutionize medical education into the 21st century.

"Final Diagnosis: No Second Chances" softcover ($15.99) and e-book ($4.99) copies of the novel can be purchased on Amazon.

For information on the novelist, medical activist, and filmmaker, visit the J.T. Madicus website.

Press Contact(s):

Stacey Barker, [email protected]
Todd Schuetz, [email protected]

SOURCE J.T. Madicus

Modal title

" Final Diagnosis: No Second Chances," the first of five works in the series by J.T. Madicus (aka: Future Doc House)
" Final Diagnosis: No Second Chances," the first of five works in the series by J.T. Madicus (aka: Future Doc House)
" Final Diagnosis: No Second Chances," the first of five works in the series by J.T. Madicus (aka: Future Doc House)

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.